Altoida Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
29
- Latest Deal Type
-
2ndary - Private
- Investors
-
18
Altoida General Information
Description
Developer of a brain health assessment and neurocognitive test platform designed to detect Alzheimer's and dementia before their onset using augmented reality. The company's application tests the functional and cognitive aptitude of a patient via a machine-learning algorithm and offers a methodology based on longitudinal clinical studies, enabling doctors to detect Alzheimer's easily and help their patients to recover early.
Contact Information
Website
www.altoida.comCorporate Office
- 80 M Street South-East
- Suite 100
- Washington, DC 20003
- United States
Corporate Office
- 80 M Street South-East
- Suite 100
- Washington, DC 20003
- United States
Altoida Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 13. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 12. Later Stage VC (Series B) | 01-Dec-2021 | Cancelled | Generating Revenue | |||
| 11. Later Stage VC (Series A) | 30-Mar-2022 | Completed | Generating Revenue | |||
| 10. Accelerator/Incubator | 09-Sep-2021 | Completed | Generating Revenue | |||
| 9. Accelerator/Incubator | 01-Jan-2020 | Completed | Generating Revenue | |||
| 8. Later Stage VC (Series A) | 17-May-2019 | Completed | Generating Revenue | |||
| 7. Accelerator/Incubator | 01-Jan-2019 | Completed | Generating Revenue | |||
| 6. Seed Round | 21-Dec-2016 | Completed | Generating Revenue | |||
| 5. Grant | $30.6M | Completed | Generating Revenue | |||
| 4. Grant | 27-Aug-2014 | $22K | Completed | Generating Revenue |
Altoida Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-2 | ||||||||
| Series A-1 | ||||||||
| Series A | 6,098,066 | $0.000100 | $0.09 | $2.36 | $2.36 | 1x | $2.36 | 24.02% |
| Seed | 1,911,761 | $0.000100 | $0.04 | $1.07 | $1.07 | 1x | $1.07 | 7.53% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Altoida Comparisons
Industry
Financing
Details
Altoida Competitors (29)
One of Altoida’s 29 competitors is NeuraMetrix, a Venture Capital-Backed company based in Asheville, NC.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| NeuraMetrix | Venture Capital-Backed | Asheville, NC | ||||
| Linus Health | Venture Capital-Backed | Dublin, Ireland | ||||
| CNS Vital Signs | Corporation | Morrisville, NC | ||||
| Aural Analytics | Formerly VC-backed | Scottsdale, AZ | ||||
| NantHealth | Formerly VC-backed | Lewisville, TX |
Altoida Patents
Altoida Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20230274835-A1 | System and method for identifying prodromal parkinson's disease | Pending | 14-Feb-2022 | ||
| EP-4430634-A1 | System and method of analysing data for the determination of the condition of a person | Pending | 09-Nov-2021 | ||
| US-20250006369-A1 | System and method of analysing data for the determination of the condition of a person | Pending | 09-Nov-2021 | ||
| WO-2023084363-A1 | System and method of analysing data for the determination of the condition of a person | Inactive | 09-Nov-2021 | ||
| JP-2024542414-A | Systems and methods for analyzing data to assess a human medical condition - patents.com | Pending | 09-Nov-2021 | G16H50/20 |
Altoida Signals
Altoida Investors (18)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| b2venture | Venture Capital | Minority | ||
| Angel (individual) | Minority | |||
| Eisai | Corporate Venture Capital | Minority | ||
| Eisai Innovation | Corporate Venture Capital | Minority | ||
| Hikma Ventures | Corporate Venture Capital | Minority |
Altoida FAQs
-
When was Altoida founded?
Altoida was founded in 2013.
-
Where is Altoida headquartered?
Altoida is headquartered in Washington, DC.
-
What is the size of Altoida?
Altoida has 29 total employees.
-
What industry is Altoida in?
Altoida’s primary industry is Decision/Risk Analysis.
-
Is Altoida a private or public company?
Altoida is a Private company.
-
What is Altoida’s current revenue?
The current revenue for Altoida is .
-
How much funding has Altoida raised over time?
Altoida has raised $21.3M.
-
Who are Altoida’s investors?
b2venture, , Eisai, Eisai Innovation, and Hikma Ventures are 5 of 18 investors who have invested in Altoida.
-
Who are Altoida’s competitors?
NeuraMetrix, Linus Health, CNS Vital Signs, Aural Analytics, and NantHealth are some of the 29 competitors of Altoida.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process